These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27197768)

  • 1. From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.
    Sarker SA; Brüssow H
    Ann N Y Acad Sci; 2016 May; 1372(1):42-52. PubMed ID: 27197768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.
    Sarker SA; Sultana S; Reuteler G; Moine D; Descombes P; Charton F; Bourdin G; McCallin S; Ngom-Bru C; Neville T; Akter M; Huq S; Qadri F; Talukdar K; Kassam M; Delley M; Loiseau C; Deng Y; El Aidy S; Berger B; Brüssow H
    EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.
    Sarker SA; Berger B; Deng Y; Kieser S; Foata F; Moine D; Descombes P; Sultana S; Huq S; Bardhan PK; Vuillet V; Praplan F; Brüssow H
    Environ Microbiol; 2017 Jan; 19(1):237-250. PubMed ID: 27750388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Dillmann ML; Kutter E; Qadri F; Sarker SA; Brüssow H
    J Bacteriol; 2004 Dec; 186(24):8287-94. PubMed ID: 15576777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T4 phages against Escherichia coli diarrhea: potential and problems.
    Denou E; Bruttin A; Barretto C; Ngom-Bru C; Brüssow H; Zuber S
    Virology; 2009 May; 388(1):21-30. PubMed ID: 19339031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.
    Bruttin A; Brüssow H
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2874-8. PubMed ID: 15980363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.
    Bourdin G; Navarro A; Sarker SA; Pittet AC; Qadri F; Sultana S; Cravioto A; Talukder KA; Reuteler G; Brüssow H
    Microb Biotechnol; 2014 Mar; 7(2):165-76. PubMed ID: 24528873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs.
    Smith HW; Huggins MB
    J Gen Microbiol; 1983 Aug; 129(8):2659-75. PubMed ID: 6355391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a T4-like phage with a relatively wide host range within Escherichia coli.
    Xu J; Chen M; He L; Zhang S; Ding T; Yao H; Lu C; Zhang W
    J Basic Microbiol; 2016 Apr; 56(4):405-21. PubMed ID: 26697952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy.
    Dalmasso M; Strain R; Neve H; Franz CM; Cousin FJ; Ross RP; Hill C
    PLoS One; 2016; 11(6):e0156773. PubMed ID: 27280590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy targeting Escherichia coli-a story with no end?
    Bolocan AS; Callanan J; Forde A; Ross P; Hill C
    FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27974392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of bacteriophages specific to multidrug resistant Escherichia coli on fecal bacterial counts and microbiome in nursery pigs.
    Imklin N; Sriprasong P; Phuttapatimok S; Kaminsonsakul T; Woonwong Y; Jirawattanapong P; Lekcharoensuk P; Thanantong N; Nasanit R
    Res Vet Sci; 2022 Dec; 151():138-148. PubMed ID: 35914451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs.
    Jamalludeen N; Johnson RP; Shewen PE; Gyles CL
    Vet Microbiol; 2009 Apr; 136(1-2):135-41. PubMed ID: 19058927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapy.
    Reynaud A; Cloastre L; Bernard J; Laveran H; Ackermann HW; Licois D; Joly B
    Vet Microbiol; 1992 Feb; 30(2-3):203-12. PubMed ID: 1532681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.
    Sarker SA; McCallin S; Barretto C; Berger B; Pittet AC; Sultana S; Krause L; Huq S; Bibiloni R; Bruttin A; Reuteler G; Brüssow H
    Virology; 2012 Dec; 434(2):222-32. PubMed ID: 23102968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice.
    Tanji Y; Shimada T; Fukudomi H; Miyanaga K; Nakai Y; Unno H
    J Biosci Bioeng; 2005 Sep; 100(3):280-7. PubMed ID: 16243277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7.
    O'Flynn G; Ross RP; Fitzgerald GF; Coffey A
    Appl Environ Microbiol; 2004 Jun; 70(6):3417-24. PubMed ID: 15184139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.